Your browser doesn't support javascript.
loading
Delivery outcomes in the subsequent pregnancy following the conservative management of placenta accreta spectrum disorder: a systematic review and meta-analysis.
Javinani, Ali; Qaderi, Shohra; Hessami, Kamran; Shainker, Scott A; Shamshirsaz, Amir A; Fox, Karin A; Mustafa, Hiba J; Subramaniam, Akila; Khandelwal, Meena; Sandlin, Adam T; Duzyj, Christina M; Lyell, Deirdre J; Zuckerwise, Lisa C; Newton, J M; Kingdom, John C; Harrison, Rachel K; Shrivastava, Vineet K; Greiner, Andrea L; Loftin, Ryan; Genc, Mehmet R; Atasi, Lamia K; Abdel-Razeq, Sonya S; Bennett, Kelly A; Carusi, Daniela A; Einerson, Brett D; Gilner, Jennifer B; Carver, Alissa R; Silver, Robert M; Shamshirsaz, Alireza A.
Affiliation
  • Javinani A; Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Qaderi S; Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Hessami K; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX.
  • Shainker SA; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Shamshirsaz AA; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX.
  • Fox KA; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX.
  • Mustafa HJ; Division of Maternal-Fetal Medicine, Indiana University School of Medicine, Indianapolis, IN; Fetal Center at Riley Children's Health, Indiana University Health, Indianapolis, IN.
  • Subramaniam A; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.
  • Khandelwal M; Cooper Medical School, Rowan University, Camden, NJ.
  • Sandlin AT; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR.
  • Duzyj CM; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA.
  • Lyell DJ; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, CA.
  • Zuckerwise LC; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN.
  • Newton JM; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN.
  • Kingdom JC; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  • Harrison RK; Department of Maternal-Fetal Medicine, Advocate Aurora Health, Chicago, IL.
  • Shrivastava VK; Miller Children's and Women's Hospital Long Beach, Long Beach Memorial Medical Center, Long Beach, CA.
  • Greiner AL; Department of Obstetrics and Gynecology, University of Iowa Hospitals & Clinics, Iowa City, IA.
  • Loftin R; Department of Maternal-Fetal Medicine, Advocate Aurora Health, Chicago, IL; Allina Health System, Minneapolis, MN.
  • Genc MR; Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, FL.
  • Atasi LK; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mercy Hospital, St. Louis, MO.
  • Abdel-Razeq SS; Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, New Haven, CT.
  • Bennett KA; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, CA; Fetal Center at Vanderbilt, Vanderbilt Universit
  • Carusi DA; Brigham & Women's Hospital, Harvard Medical School, Boston, MA.
  • Einerson BD; Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT.
  • Gilner JB; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, NC.
  • Carver AR; Wilmington Maternal-Fetal Medicine, Wilmington, NC.
  • Silver RM; Department of Obstetrics and Gynecology, University of Utah School of Medicine, Salt Lake City, UT.
  • Shamshirsaz AA; Maternal Fetal Care Center, Boston Children's Hospital, Harvard Medical School, Boston, MA. Electronic address: alireza.shamshirsaz@childrens.harvard.edu.
Am J Obstet Gynecol ; 2023 Nov 02.
Article in En | MEDLINE | ID: mdl-37918506
OBJECTIVE: Cesarean hysterectomy is generally presumed to decrease maternal morbidity and mortality secondary to placenta accreta spectrum disorder. Recently, uterine-sparing techniques have been introduced in conservative management of placenta accreta spectrum disorder to preserve fertility and potentially reduce surgical complications. However, despite patients often expressing the intention for future conception, few data are available regarding the subsequent pregnancy outcomes after conservative management of placenta accreta spectrum disorder. Thus, we aimed to perform a systematic review and meta-analysis to assess these outcomes. DATA SOURCES: PubMed, Scopus, and Web of Science databases were searched from inception to September 2022. STUDY ELIGIBILITY CRITERIA: We included all studies, with the exception of case studies, that reported the first subsequent pregnancy outcomes in individuals with a history of placenta accreta spectrum disorder who underwent any type of conservative management. METHODS: The R programming language with the "meta" package was used. The random-effects model and inverse variance method were used to pool the proportion of pregnancy outcomes. RESULTS: We identified 5 studies involving 1458 participants that were eligible for quantitative synthesis. The type of conservative management included placenta left in situ (n=1) and resection surgery (n=1), and was not reported in 3 studies. The rate of placenta accreta spectrum disorder recurrence in the subsequent pregnancy was 11.8% (95% confidence interval, 1.1-60.3; I2=86.4%), and 1.9% (95% confidence interval, 0.0-34.1; I2=82.4%) of participants underwent cesarean hysterectomy. Postpartum hemorrhage occurred in 10.3% (95% confidence interval, 0.3-81.4; I2=96.7%). A composite adverse maternal outcome was reported in 22.7% of participants (95% confidence interval, 0.0-99.4; I2=56.3%). CONCLUSION: Favorable pregnancy outcome is possible following successful conservation of the uterus in a placenta accreta spectrum disorder pregnancy. Approximately 1 out of 4 subsequent pregnancies following conservative management of placenta accreta spectrum disorder had considerable adverse maternal outcomes. Given such high incidence of adverse outcomes and morbidity, patient and provider preparation is vital when managing this population.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Am J Obstet Gynecol Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Am J Obstet Gynecol Year: 2023 Type: Article